Suprachoroidal steroids for uveitic macular oedema: Teaching an old drug new tricks?

Clin Exp Ophthalmol. 2022 Jan;50(1):14-16. doi: 10.1111/ceo.14033.

Authors

Thomas Gordon Campbell^{1

2

3}, Ming-Lee Lin^{3

4}

Affiliations

¹ Centre for Eye Research Australia, East Melbourne, Victoria, Australia.
² Ophthalmology, Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia.
³ Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.
⁴ Department of Ophthalmology, Alfred Health, Melbourne, Victoria, Australia.

PMID: 35165995
DOI: 10.1111/ceo.14033

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Glucocorticoids / therapeutic use
Humans
Macular Edema* / diagnosis
Macular Edema* / drug therapy
Macular Edema* / etiology
Triamcinolone Acetonide / therapeutic use
Uveitis* / complications
Uveitis* / diagnosis
Uveitis* / drug therapy

Substances

Glucocorticoids
Triamcinolone Acetonide